<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03360110</url>
  </required_header>
  <id_info>
    <org_study_id>CV-17-60</org_study_id>
    <nct_id>NCT03360110</nct_id>
  </id_info>
  <brief_title>Comparison of New Contact Lens With Current Marketed Lens</brief_title>
  <official_title>Clinical Validation Study of Phoebe Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coopervision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coopervision, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to validate the clinical performance of a new contact lens
      design.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evaluate the clinical performance of its Phoebe contact lenses (Test) compared to the
      commercially available MyDay contact lenses (Control). The primary study hypothesis is that
      the Phoebe contact lens performs substantially equivalent to the MyDay contact lens for
      ocular health.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 6, 2017</start_date>
  <completion_date type="Actual">December 15, 2017</completion_date>
  <primary_completion_date type="Actual">December 15, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Double masked (participant, investigator)</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Stromal haze</measure>
    <time_frame>Up to 3 days</time_frame>
    <description>Measurement of haze in stroma, graded 0-4 (0=none, 4=dense) in 0.25 steps</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Corneal neovascularization</measure>
    <time_frame>Up to 3 days</time_frame>
    <description>Measurement of neovascularization of the cornea; graded 0-4 (0=no change, 4=severe) in 0.25 steps</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bulbar and limbal hyperemia</measure>
    <time_frame>Up to 3 days</time_frame>
    <description>Measurement of hyperemia of the bulbar and limbal conjunctiva; graded 0-4 (0=no change, 4=severe) in 0.25 steps</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Palpebral hyperemia</measure>
    <time_frame>Up to 3 days</time_frame>
    <description>Measurement of hyperemia of the palpebral conjunctiva; graded 0-4 (0=none, 4=severe) in 0.25 steps</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Palpebral roughness</measure>
    <time_frame>Up to 3 days</time_frame>
    <description>Measurement of smoothness of palpebral conjunctiva; graded 0-4 (0=smooth, 4=severe) in 0.25 steps</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Corneal staining</measure>
    <time_frame>Up to 3 days</time_frame>
    <description>Measurement of amount of corneal staining; graded 0-4 (0=none, 4=severe), in 0.50 steps</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Acuity</measure>
    <time_frame>Up to 3 days</time_frame>
    <description>Visual acuity recorded in logMAR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vision Quality</measure>
    <time_frame>Up to 3 days</time_frame>
    <description>Vision quality scored on a 0-10 scale (0=extremely poor, 10=excellent)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">53</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>Test lens</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects randomized to wear pair of test lens either first or second</description>
  </arm_group>
  <arm_group>
    <arm_group_label>stenfilcon A lens (control)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects randomized to wear pair of control lens either first or second</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Phoebe test lens</intervention_name>
    <description>Daily disposable contact lens</description>
    <arm_group_label>Test lens</arm_group_label>
    <arm_group_label>stenfilcon A lens (control)</arm_group_label>
    <other_name>Test Lens</other_name>
    <other_name>Phoebe Contact Lens</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>stenfilcon A lens (control)</intervention_name>
    <description>Daily disposable contact lens</description>
    <arm_group_label>Test lens</arm_group_label>
    <arm_group_label>stenfilcon A lens (control)</arm_group_label>
    <other_name>MyDay daily disposable contact lens</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria

        A person is eligible for inclusion in the study if he/she:

          -  Between and 18 and 35 years of age and has full legal capacity to volunteer

          -  Has had a self-reported oculo-visual examination in the last two years

          -  Has read and understood the information consent letter

          -  Is willing and able to follow instructions and maintain the appointment schedule

          -  Is correctable to a visual acuity of 20/25 or better (in each eye) with their habitual
             correction or 20/20 best corrected

          -  Has a Contact Lens Refraction between -1.00D and -6.00D

          -  Cylinder power â‰¤ -0.75DC in Spherical Cylindrical Refraction

          -  Currently wears soft contact lenses

          -  Is willing to wear lenses for a minimal of 8 hours a day and everyday during the
             course of the study

          -  Has clear corneas and no active ocular disease

          -  Has not worn lenses for at least 12 hours before the first visit

        Exclusion Criteria

        A person will be excluded from the study if he/she:

          -  Has never worn contact lenses before

          -  Is wearing Monovision modality

          -  Has any systemic disease affecting ocular health

          -  Is using any systemic or topical medications that will affect ocular health

          -  Has any ocular pathology or severe insufficiency of lacrimal secretion (moderate to
             severe dry eyes) that would affect the wearing of contact lenses

          -  Has persistent, clinically significant corneal or conjunctival staining using sodium
             fluorescein dye

          -  Has any clinically significant lid or conjunctival abnormalities, active
             neovascularization or any central corneal scars

          -  Is aphakic

          -  Has undergone corneal refractive surgery

          -  Is participating in any other type of eye related clinical or research study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter S Kolbaum, O.D., Ph.D., FAAO, FBCLA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Optics Research Lab (CORL), Indiana University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinical Optical Research Lab (CORL)</name>
      <address>
        <city>Bloomington</city>
        <state>Indiana</state>
        <zip>47405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>November 21, 2017</study_first_submitted>
  <study_first_submitted_qc>November 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 2, 2017</study_first_posted>
  <disposition_first_submitted>June 3, 2019</disposition_first_submitted>
  <disposition_first_submitted_qc>June 3, 2019</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">June 6, 2019</disposition_first_posted>
  <last_update_submitted>June 6, 2019</last_update_submitted>
  <last_update_submitted_qc>June 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>September 28, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/10/NCT03360110/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

